Blood Plasma Market – Industry Size, Share & Analysis 2019-2027
                     BLOOD PLASMA MARKET 
2019-2027
o According to Triton Market Research, the 
global market for blood plasma is expected 
to display a positive market trend over the 
forecast period of 2019-2027, exhibiting a 
CAGR of 6.13%.
o Plasma, the principal constituent of blood, 
plays a pivotal role in regulating the body’s 
functions. It is composed of various useful 
elements, such as immunoglobulins, 
coagulation factors, albumin and protease 
inhibitors. Since insufficiencies in a 
component can give rise to disease, both 
basic and targeted research & development 
has begun in this field. 
o Blood plasma is part of an effective 
therapeutic plan of treatment in numerous 
therapies due to its potential in combatting 
several diseases, like leukemia, hemophilia, 
immunodeficiency and other bleeding 
diseases, which are chronic and life-
threatening. 
o Blood plasma products have proven to be a 
blessing for patients suffering from such 
conditions, which has demanded a more 
comprehensive knowledge of their 
applications.
MARKET OUTLOOK 
REGIONAL OUTLOOK
• The global blood plasma market spans acros s  the 
regions of North America, the Middle East and Africa, 
Latin America, Europe and the Asia-Pacific.
• The Asia-Pacific blood plasma market was the fastest 
growing market over the world, in terms of CAGR. The 
APAC region offers extensive opportunities for the 
expansion of the blood plasma market. 
• The Asia-Pacific Blood Network (APBN) is a non-profit 
organization with strategic leadership policies for the 
regulation of its members’ activities, in a bid to 
increase the plasma supply across the region. 
Established in 2006, the network aims to provide the 
safe, steady and cost-efficient supply of blood and its 
components. 
• Japan has dominated the Asia-Pacific market due to the 
rise in the number of its organizations that ensure the 
supply of blood plasma. China was second in significant 
contributions to the blood plasma market.
REQUEST FREE 
SAMPLE!
  
Global market for blood plasma is 
expected to display a positive market 
trend over the forecast period of 2019-
2027, exhibiting a CAGR of 6.13%.
https://www.tritonmarketresea
rch.com/reports/global-blood-p
lasma-market
REQUEST FREE 
SAMPLE!
Request Free Sample @ 
https://www.tritonmarketresearch.com/reports/global-blood-plasma-market
INFOGRAPHIC
Request Free Sample @ 
https://www.tritonmarketresearch.com/reports/north-america-blood-plasma
-market
NORTH AMERICA
Request Free Sample @ 
https://www.tritonmarketresearch.com/reports/europe-blood-plasma-marke
t
EUROPE
Request Free Sample @ 
https://www.tritonmarketresearch.com/reports/asia-pacific-blood-plasma
-market
ASIA PACIFIC
Request Free Sample @ 
https://www.tritonmarketresearch.com/reports/latin-america-blood-plasm
a-market
LATIN AMERICA
Request Free Sample @ 
https://www.tritonmarketresearch.com/reports/middle-east-and-africa-blood-plas
ma-market
MIDDLE EAST & 
AFRICA
COMPETITIVE 
OUTLOOK
The companies that have been mentioned in 
the market report are Cerus Corp., General   
Electric, Co., China Biologic Products, Inc., 
ADMA Biologics, Inc., CSL Ltd., Biotest AG, 
Grifols International S.A., Baxter International, 
Inc., Octapharma AG, Arthrex and Shire Plc.
Biotest AG is an international company that 
supplies plasma protein & biotherapeutic 
drugs and manufactures products used in 
various therapeutic disciplines including 
clinical immunology, hematology and 
intensive care medicine. The company has 
achieved expertise in the production of 
immunoglobulins, clotting factors and 
albumin, along with monoclonal antibodies 
used in clinical development.
UK OFFICE
196, wards wharf approach 
London E16 2EQ
INDIA OFFICE
Navjivan CHS Block No.02/08, 
S.B.Marg Bhagwansingh 
Colony, Matunga West Mumbai 
MH 400016
CONTAC
T US
WWW Tritonmarketresearch.
com THANK 
@Tritonmarketresearch YOU
@Tritonmarketresearch
@Tritonmarketresearch
@Tritonmarketresearch